Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Is It Time to Dump Your Shares of Canopy Growth?
Canopy Growth (CGC +3.36%) is a leader in the Canadian marijuana market. An early mover in the sector, the stock has gone through two massive price swings. Today, however, the stock is trading at around $1 per share, off from its all-time high of $568 by a whopping 99%. It may be time to consider selling the stock if you’re sitting on material paper losses.
Marijuana stocks haven’t worked out the way Wall Street had hoped
Wall Street often gets overly excited about hot investment ideas, pushing stocks to unrealistic extremes. That’s exactly what happened with the marijuana sector, with a couple of massive stock rallies that priced stocks like Canopy Growth for complete perfection. But the marijuana business didn’t prove to be quite as profitable as investors had hoped.
Image source: Getty Images.
Notably, competition in the legal marijuana space has been fierce. And illicit marijuana sales haven’t stopped, so there are still competitors that don’t have to deal with the costs of regulation and taxes. Canopy Growth, for its part, has yet to turn a sustainable profit.
How much have you lost?
To be fair, Canopy Growth has been inching closer and closer to black ink. But there are still several worrying facts to consider.
For example, it recently recapitalized its balance sheet, which has left it in a stronger financial position. But the fact that it had to take this action isn’t a particularly good sign. Meanwhile, it is working on an acquisition to be funded with a mix of cash and stock. The deal will strengthen Canopy’s position in the medical marijuana space, but the cash being spent will weaken the balance sheet, and the stock issued will dilute existing shareholders.
Expand
NASDAQ: CGC
Canopy Growth
Today’s Change
(3.36%) $0.04
Current Price
$1.07
Key Data Points
Market Cap
$362M
Day’s Range
$1.03 - $1.08
52wk Range
$0.77 - $2.38
Volume
406K
Avg Vol
26M
Gross Margin
18.25%
If you bought the stock recently, there’s probably no reason to sell it. Presumably, you believe a turnaround is unfolding. That might actually be true. However, if you have large paper losses because you bought it at much higher levels, it might make sense to harvest those losses so you can offset capital gains taxes elsewhere in your portfolio. The big problem is that a return to the stock’s all-time highs seems unlikely in the near future, given the mix of positive and negative news around the business.
Sometimes it is better to admit mistakes and move on. The ability to harvest losses for tax purposes helps soften the blow, but don’t forget the lesson: Buying during periods of unbridled enthusiasm can turn good ideas into bad investments.